Effects of nitrogen rates on grain yield and nitrogen agronomic efficiency of durum wheat genotypes under different environments

Durum wheat is an important staple food crop in Tunisia and other Mediterranean countries and is grown in various climatic conditions. Production and yield are however severely limited not only by drought events but also by reduced levels of nitrogen fertilisation. A study was carried out at two locations in the sub-humid area of Tunisia: Mateur in 2009–10 and 2010–11 and Beja in 2011–12 and 2012–13 under rainfed conditions. Four durum wheat genotypes (landraces: Bidi, Azizi; improved: Om Rabia, Khiar) were evaluated for nitrogen agronomic efficiency and related agronomic traits under various nitrogen rates: 0, 50, 100, 150, 200 and 250 kgNha−1, with three replications. There was a significant interaction effect (P ≤ 0.001) environments × genotypes ×N treatments for grain yield (GY), biomass yield (BY), harvest index (HI), partial factor productivity of applied nitrogen (PFPN) and nitrogen agronomic use efficiencies (NAE). GY was the most affected trait by nitrogen applied showing an increase of 94% under high N treatment (250 kgNha−1) compared to control plots without N treatments. A significant linear regression exists between GY (0 N) and GY for the different N rates (r =0.70; P < 0.001). This effect was more pronounced for improved genotypes than landraces for all parameters excepting BY and NAEBY. BY showed +11% increase in landraces than improved genotypes. PFPN showed an average decrease of 65% under high-N fertilisation with 10% prevalence for improved genotypes. Landraces tend to promote vegetative growth while grain filling efficiency was higher for improved genotype

Airway smooth muscle cells from severe asthma patients with fixed airflow obstruction are responsive to steroid and bronchodilator treatment in vitro

Asthma is characterised by recurrent symptoms associated with variable airflow obstruction and airway hyperresponsiveness, all of which are improved with combination inhaled corticosteroid (ICS)/long-acting β-agonist (LABA) treatment in mild-to-moderate asthma [1]. A proportion of patients however develop fixed airflow obstruction (FAO), despite optimised treatment. FAO is prevalent in up to 60% of patients with severe asthma and is associated with a more rapid decline in lung function and increased symptoms [2]. The underlying mechanisms of FAO in asthma are poorly understood; therefore, development of novel treatment strategies remains a challenge. Airway smooth muscle cells (ASMCs) are the major effector cells of bronchoconstriction in asthma and also contribute to the inflammatory process by secreting pro-inflammatory cytokines and chemokines. Therefore, ASMCs are a major target of both β2-agonist and ICS treatment [3]. Although several studies have suggested that steroid signalling [4] or β2-adrenoceptor (β2AR) signalling may be abnormally regulated in severe asthma [5], it remains unknown whether impaired airway smooth muscle corticosteroid and/or β2-agonist response may contribute to the development of FAO. The aim of this study was to investigate whether primary human ASMCs obtained from severe asthma patients with FAO differ in their response to β2-agonists and corticosteroids compared with asthma patients without FAO and healthy controls. We hypothesised that ASMCs from asthma patients with FAO are less responsive to corticosteroid and β2-agonist treatment than those from patients without FA

A Fully Integrated Electrochemical BioMEMS Fabrication Process for Cytokine Detection: Application for Heart Failure

AbstractIn this present study, a fully integrated BioMEMS was developed using silicon technology to simultaneously detect varying cytokine biomarkers: interleukin-1 (IL-1), interleukin-10 (IL-10), and interleukin-6 (IL-6) using eight gold working microelectrodes (WE). The biomarkers are one of many antigens that are secreted in acute stages of inflammation after left ventricle assisted device (LVAD) implantation for patients suffering from heart failure (HF). The monoclonal antibodies (mAb): anti-human IL-1, IL-10, and IL-6 were immobilized onto gold microelectrodes through functionalization with carboxyl diazonium, respectively. Cyclic voltammetry (CV) was applied during the microelectrode functionalization process to characterize the gold microelectrode surface properties, while electrochemical impedance spectroscopy (EIS) was used to characterize the modified gold microelectrodes. The BioMEMS was highly sensitive towards the three cytokines in a range of 1 pg/mL to 15 pg/mL, which is the window where acute inflammations were observed

Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction

© 2017 Turturice et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background: Differences in asthma severity may be related to inflammation in the airways. The lower airway microbiota has been associated with clinical features such as airway obstruction, symptom control, and response to corticosteroids. Objective: To assess the relationship between local airway inflammation, severity of disease, and the lower airway microbiota in atopic asthmatics. Methods: A cohort of young adult, atopic asthmatics with intermittent or mild/moderate persistent symptoms (n = 13) were assessed via bronchoscopy, lavage, and spirometry. These individuals were compared to age matched non-asthmatic controls (n = 6) and to themselves after six weeks of treatment with fluticasone propionate (FP). Inflammation of the airways was assessed via a cytokine and chemokine panel. Lower airway microbiota composition was determined by metagenomic shotgun sequencing. Results: Unsupervised clustering of cytokines and chemokines prior to treatment with FP identified two asthmatic phenotypes (AP), termed AP1 and AP2, with distinct bronchoalveolar lavage inflammatory profiles. AP2 was associated with more obstruction, compared to AP1. After treatment with FP reduced MIP-1β and TNF-α and increased IL-2 was observed. A module of highly correlated cytokines that include MIP-1β and TNF-α was identified that negatively correlated with pulmonary function. Independently, IL-2 was positively correlated with pulmonary function. The airway microbiome composition correlated with asthmatic phenotypes. AP2, prior to FP treatment, was enriched with Streptococcus pneumoniae. Unique associations between IL-2 or the cytokine module and the microbiota composition of the airways were observed in asthmatics subjects prior to treatment but not after or in controls. Conclusion: The underlying inflammation in atopic asthma is related to the composition of microbiota and is associated with severity of airway obstruction. Treatment with inhaled corticosteroids was associated with changes in the airway inflammatory response to microbiota

Variation of Grain Yield, Grain Protein Content and Nitrogen Use Efficiency Components under Different Nitrogen Rates in Mediterranean Durum Wheat Genotypes

Nitrogen (N) is a crucial nutrient for plant growth and development. To optimize agricultural environments, N fertilizers represent a critical tool to regulate crop productivity. The improvement of nitrogen use efficiency (NUE) represents a promising tool that may enable cereal production to meet future food demand. Wheat reported contrasting behaviors in N utilization showing specific abilities depending on genotype. This study selected two landraces and two improved genotypes from Northern Africa to investigate grain yield (GY), grain protein content (GPC) and NUE. Plants were grown under three levels of N supply: 0, 75, 150 kg N ha−1 and for two consecutive years. Results reported a better NUE (0.40 kg.kg N−1) obtained under 150 kg N ha−1, while N utilization efficiency (NUtE) showed a 13% increase using 75 kg N ha−1 compared with 150 kg N ha−1. Under low nitrogen rate (0 N), crop N supply (CNS) and N uptake efficiency (NUpE) were shown as determinant factors for improved genotypes GY (R2 = 0.72), while NUtE represented the most determinant component for GPC in landraces (R2 = 0.92). Multivariate regression models explained the dependence in GPC on NUE, NUpE, and NUtE. In conclusion, our results recognize GPC and NUtE as suitable selection traits to identify durum wheat with higher NUE

Fibulin-1 Is Increased in Asthma – A Novel Mediator of Airway Remodeling?

Background: The extracellular matrix is a dynamic and complex network of macromolecules responsible for maintaining and influencing cellular functions of the airway. The role of fibronectin, an extracellular matrix protein, is well documented in asthma. However, the expression and function of fibulin-1, a secreted glycoprotein which interacts with fibronectin, has not been reported. Fibulin-1 is widely expressed in basement membranes in many organs including the lung. There are four isoforms in humans (A-D) of which fibulin-1C and 1D predominate. The objective of this study was to study the expression of fibulin-1 in volunteers with and without asthma, and to examine its function in vitro. Methodology/Principal Findings: We used immunohistochemistry and dot-blots to examine fibulin-1 levels in bronchial biopsies, bronchoalveolar lavage fluid and serum. Real-time PCR for fibulin-1C and 1D, and ELISA and western blotting for fibulin-1 were used to study the levels in airway smooth muscle cells. The function of fibulin-1C was determined by assessing its role, using an antisense oligonucleotide, in cell proliferation, migration and wound healing. A murine model of airway hyperresponsiveness (AHR) was used to explore the biological significance of fibulin-1. Levels of fibulin-1 were significantly increased in the serum and bronchoalveolar lavage fluid of 21 asthmatics compared with 11 healthy volunteers. In addition fibulin-1 was increased in asthma derived airway smooth muscle cells and fibulin-1C contributed to the enhanced proliferation and wound repair in these cells. These features were reversed when fibulin-1C was suppressed using an antisense oligomer. In a mouse model of AHR, treatment with an AO inhibited the development of AHR to methacholine. Conclusions: Our data collectively suggest fibulin-1C may be worthy of further investigation as a target for airway remodeling in asthma

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Background:Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. Methods:Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of the following severe asthma definitions were included: 1) Global Initiative for Asthma step 4 treatment with poor asthma control (asthma control questionnaire score ≥0.75); 2) International Severe Asthma Registry definition; 3) American Thoracic Society and European Respiratory Society severe asthma definitions. The rate of total exacerbations was calculated for each subgroup and efficacy of azithromycin compared with placebo. Asthma-related quality of life was assessed before and after treatment along with adverse effects. Results:Azithromycin significantly reduced asthma exacerbations in each group. In patients meeting the American Thoracic Society and European Respiratory Society task force definition of severe asthma (n=211), the rate of exacerbations with treatment was 1.2 per person-year, which was significantly less than for placebo (2.01 per person-year), giving an incidence rate ratio (95% CI) of 0.63 (0.41, 0.96). The proportion of participants experiencing at least one asthma exacerbation was reduced by azithromycin from 64% to 49% (p=0.021). A similar beneficial treatment effect was seen in participants poorly controlled with Global Initiative for Asthma step 4 treatment and those with International Severe Asthma Registry-defined severe asthma. Azithromycin also significantly improved the quality of life in severe asthma (p<0.05). Treatment was well tolerated, with gastrointestinal symptoms being the main adverse effect. Conclusion:Long-term, low-dose azithromycin reduced asthma exacerbations and improved the quality of life in patients with severe asthma, regardless of how this was defined. These data support the addition of azithromycin as a treatment option for patients with severe asthma.Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James ... et al

Fibulin-1 is increased in asthma – A novel mediator of airway remodeling?

Background The extracellular matrix is a dynamic and complex network of macromolecules responsible for maintaining and influencing cellular functions of the airway. The role of fibronectin, an extracellular matrix protein, is well documented in asthma. However, the expression and function of fibulin-1, a secreted glycoprotein which interacts with fibronectin, has not been reported. Fibulin-1 is widely expressed in basement membranes in many organs including the lung. There are four isoforms in humans (A–D) of which fibulin-1C and 1D predominate. The objective of this study was to study the expression of fibulin-1 in volunteers with and without asthma, and to examine its function in vitro. Methodology/Principal Findings We used immunohistochemistry and dot-blots to examine fibulin-1 levels in bronchial biopsies, bronchoalveolar lavage fluid and serum. Real-time PCR for fibulin-1C and 1D, and ELISA and western blotting for fibulin-1 were used to study the levels in airway smooth muscle cells. The function of fibulin-1C was determined by assessing its role, using an antisense oligonucleotide, in cell proliferation, migration and wound healing. A murine model of airway hyperresponsiveness (AHR) was used to explore the biological significance of fibulin-1. Levels of fibulin-1 were significantly increased in the serum and bronchoalveolar lavage fluid of 21 asthmatics compared with 11 healthy volunteers. In addition fibulin-1 was increased in asthma derived airway smooth muscle cells and fibulin-1C contributed to the enhanced proliferation and wound repair in these cells. These features were reversed when fibulin-1C was suppressed using an antisense oligomer. In a mouse model of AHR, treatment with an AO inhibited the development of AHR to methacholine. Conclusions Our data collectively suggest fibulin-1C may be worthy of further investigation as a target for airway remodeling in asthma